Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. METHODS AND FINDINGS: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). CONCLUSIONS: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence have shown that the composition of the gut microbiota is altered in animal models of obesity and subjects with prediabetes or type 2 diabetes compared with controls (182–186).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Chronic autoimmune inflammatory diseases, including celiac disease,17 type 2 diabetes18 and obesity19 are associated with intestinal dysbiosis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [18]
In the citing paper
“Conversely, heterocyclic amines and glycan derived from red meat may promote inflammation in gut health due to higher concentration of Bacteroides and Fusobacterium and lower levels of Lactobacillus and Roseburia, which are also linked with lower anti-inflammatory responses and increased incidence of type 2 diabetes [191,192,193].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[RETRACTION]Translational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A., & Saad, M. J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200004 · Cited by 44
RetractedTranslational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M. L., Carvalho, B. M., Filho, C., & Saad, M. J. A. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900014 · Cited by 17
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“The differences in microbial composition were explained by an increased capacity of the obesity-associated microbiome to harvest energy from the diet [13].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 2×
“For example, levels of Bifidobacterium significantly and positively correlated with improved glucose-tolerance and low-grade inflammation in prebiotic treated-mice [1,6].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Cited by
Items 801–900 of 1,020
Gomes, J. M. G., Costa, J. A., & Alfenas, R. C. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515003608 · Cited by 72
H. pylori Eradication Treatment Alters Gut Microbiota and GLP-1 Secretion in Humans
Cornejo-Pareja, I. M., Martín‐Núñez, G. M., ROCA-RODRIGUEZ, M. M., Cardona, F., Coín‐Aragüez, L., Sánchez‐Alcoholado, L., Gutiérrez‐Repiso, C., Muñoz‐Garach, A., Fernández‐García, J. C., Moreno‐Indias, I., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040451 · Cited by 74
“Many studies [5,24,25] have explored how modulation of the microbiota plays an important role in carbohydrate metabolism, with improved glycemic control and insulin sensitivity, which can occur through multiple pathways including modulation of incretin hormones by the microbiota.”
BackgroundIsmael, S., Silvestre, M. P., Vasques, M., Araújo, J. R., Morais, J., Duarte, M. I., Pestana, D., Faria, A., Pereira‐Leal, J. B., Vaz, J., et al. (2021) · Nutrients · doi:10.3390/nu13041228 · Cited by 84
“[40], which results in higher metabolic endotoxemia and inflammation [39].”
BackgroundAlteration of Gut Microbiota in Alzheimer’s Disease and Their Relation to the Cognitive Impairment
Khedr, E. M., Omeran, N., Ramadan, H. K., Ahmed, G. K., & Abdelwarith, A. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220176 · Cited by 78
“A reduction in Firmicutes has been reported in patients with type 2 diabetes [57], obesity [58–60], and Parkinson’s disease [5].”
Ethanol extract of propolis regulates type 2 diabetes in mice via metabolism and gut microbiota
Guan, R., Ma, N., Liu, G., Qiu, W., Su, S., Wang, J., & Geng, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116385 · Cited by 74
Ayesha, I. E., Monson, N. R., Klair, N., Patel, U. P., Saxena, A., Patel, D. N., & Venugopal, S. (2023) · Cureus · doi:10.7759/cureus.46741 · Cited by 94
Yu, Y., Ding, Y., Wang, S., & Jiang, L. (2025) · Metabolites · doi:10.3390/metabo15060397 · Cited by 81
“In recent years, emerging research has provided new perspectives for understanding the role of microbiota dysbiosis in T2DM pathogenesis [19–21].”
The Human Microbiome and Surgical Disease
Morowitz, M. J., BABROWSKI, T. A., Carlisle, E. M., Olivas, A. D., Romanowski, K. S. S., Seal, J. B., Liu, D. C., & Alverdy, J. C. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31821175d7 · Cited by 73
Hashemi, Z., Fouhse, J., Im, H., Chan, C., & Willing, B. (2017) · Nutrients · doi:10.3390/nu9111236 · Cited by 70
Composition and diversity of gut microbiota in diabetic retinopathy
Bai, J., Wan, Z., Zhang, Y., Wang, T., Xue, Y., & Peng, Q. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.926926 · Cited by 70
“This finding was consistent with previous studies, wherein the association between Firmicutes and Bacteroidetes had been reported in diabetic patients (Larsen et al., 2010), and the alterations of the composition and function of gut microbiota in metabolic diseases, especially T2DM, were confirmed (Qin et al.”
ResultPrajapati, B., Jena, P., Rajput, P., Purandhar, K., & Seshadri, S. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140515112609 · Cited by 71
Characteristics of the gut microbiome in patients with prediabetes and type 2 diabetes
Zhang, Z., Tian, T., Chen, Z., Liu, L., Luo, T., & Dai, J. (2021) · PeerJ · doi:10.7717/peerj.10952 · Cited by 74
What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?
González-Franquesa, A., Burkart, A., ISGANAITIS, E. M., & Patti, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0763-1 · Cited by 78
Human microflora, probiotics and wound healing
Tsiouris, C. G., & Tsiouri, M. G. (2017) · Wound Medicine · doi:10.1016/j.wndm.2017.09.006 · Cited by 76
Gowd, V., Xie, L., Zheng, X., & Chen, W. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2019.1576025 · Cited by 73
“18 Control and 18 diabetes (male), q-PCR, 16s RNA gene The significant decrease in abundance of phylum Firmicutes and class Clostridia, increase in abundance of class Betaproteobacteria was found in diabetes subjects The change in GM positively and significantly correlated with plasma glucose concentrations [10]”
BackgroundInfluentialRethinking mechanisms of autoimmune pathogenesis
Pillai, S. S. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.05.003 · Cited by 73
Xue, M., Liu, Y., Xu, H., Zhou, Z., Ma, Y., Sun, T., Liu, M., Zhang, H., & Liang, H. W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109393 · Cited by 70
“In humans, Larsen, et al [30] studied the fecal bacterial composition of 36 adult males.”
BackgroundXu, T., Ge, Y., Du, H., Li, Q., Xu, X., Yi, H., Wu, X., Kuang, T., Fan, G., & Zhang, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113995 · Cited by 79
Chocolate as Carrier to Deliver Bioactive Ingredients: Current Advances and Future Perspectives
Faccinetto-Beltrán, P., Gómez‐Fernández, A. R., Santacruz, A., & Jacobo‐Velázquez, D. A. (2021) · Foods · doi:10.3390/foods10092065 · Cited by 73
Gut Microbiome Changes in Gestational Diabetes
Ionescu, R. F., Enache, R. M., Creţoiu, S. M., & Gașpar, B. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112839 · Cited by 73
“As a conclusion, Firmicutes to Bacteroidetes ratios were significantly and positively correlated with reduced glucose tolerance [70].”
BackgroundMansour, S., Alkhaaldi, S. M. I., Sammanasunathan, A. F., Ibrahim, S. M., Farhat, J., & Al‐Omari, B. (2024) · Nutrients · doi:10.3390/nu16050581 · Cited by 80
“The intestinal microbial flora also differs, with lower Firmicutes seen in diabetic patients when compared to the non-diabetic healthy controls [161,162].”
BackgroundZhang, Y., Guo, X. Q., Guo, J., He, Q., Li, H., Song, Y., & Zhang, H. (2014) · Scientific Reports · doi:10.1038/srep05654 · Cited by 70
“(1) 1 (2), (3) 1 (4) and (1) 1 (2) 1 (3) 1 (4) stand for primary,”
A robust approach for identifying differentially abundant features in metagenomic samples
Sohn, M. B., Du, R., & An, L. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv165 · Cited by 78
Microbial Regulation of Glucose Metabolism and Insulin Resistance
Crommen, S., & Simon, M.-C. (2017) · Genes · doi:10.3390/genes9010010 · Cited by 65
“Obese humans and rodents have less diverse gut communities than their lean counterparts [58,136,137], and likewise, metagenomic studies have documented differences in the microbiota represented in the gut communities of individuals with obesity and T2D [65,138,139].”
BackgroundBierlich, K. C., Miller, C. A., DeForce, E., Friedlaender, A. S., Johnston, D. W., & Apprill, A. M. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02574-17 · Cited by 69
“Recent evidence indicates that communities of microorganisms (microbiomes) associated with animals, including humans, provide an indication of health, as well as other individual traits (6, 7).”
Verdugo‐Meza, A., Ye, J., Dadlani, H., Ghosh, S., & Gibson, D. L. (2020) · Nutrients · doi:10.3390/nu12051434 · Cited by 72
“Decreased richness is a common feature between IBD, obesity, insulin resistance, T2DM and NAFLD; while an increase in Proteobacteria and decrease in Firmicutes is a common trait for IBD [41], insulin resistance [42], T2DM [43], NAFLD [44] and atherosclerosis [45].”
BackgroundMastrocola, R., Ferrocino, I., Liberto, E., Chiazza, F., Cento, A. S., Collotta, D., Querio, G., Nigro, D., Bitonto, V., Cutrin, J. C., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.003 · Cited by 68
Microbiome of HIV-infected people
Dubourg, G., Surénaud, M., Lévy, Y., Hüe, S., & Raoult, D. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.05.015 · Cited by 70
Recent Advances in Psoriasis Research; the Clue to Mysterious Relation to Gut Microbiome
Komine, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072582 · Cited by 72
“Recent studies linked cardiac disease, insulin resistance, and metabolic syndrome to gut microbiota [37,38].”
BackgroundWu, Q., Wu, S., Yang, C., Zhang, Z., Mao, G., Li, S., Yang, Y., Zhang, X., Wu, M., & Tong, H. (2021) · Food & Function · doi:10.1039/d0fo03329d · Cited by 73
Gregory, A., Gerhardt, K., Zhong, Z.-P., Bolduc, B., Temperton, B., Konstantinidis, K. T., & Sullivan, M. B. (2022) · Microbiome · doi:10.1186/s40168-022-01231-0 · Cited by 75
Metformin, Cognitive Function, and Changes in the Gut Microbiome
Rosell-Díaz, M., & Fernández‐Real, J. M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad029 · Cited by 72
Zikou, E., Dovrolis, N., Dimosthenopoulos, C., Gazouli, M., & Makrilakis, K. (2023) · Nutrients · doi:10.3390/nu15214663 · Cited by 76
“…in the intestinal microbiome are likely associated with the development of T2D, with diabetic patients exhibiting distinct microbiome profiles compared to healthy individuals, often marked by reduced populations of beneficial butyrate-producing bacteria and an increase in various pathogens [14].”
BackgroundZikou, E., Koliaki, C. C., & Makrilakis, K. (2024) · Biomedicines · doi:10.3390/biomedicines12081871 · Cited by 83
“In the same direction, the stability, abundance, and qualitative composition of gut microbiota have been linked to the development of T2DM and its associated complications, as patients with T2DM have distinctly different gut microbiota compared to non-diabetic individuals [26].”
BackgroundResponsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics
O’Connor, A., Quizon, P. M., Albright, J. E., Lin, F. T., & Bennett, B. J. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9540-0 · Cited by 67
“to and development of several chronic metabolic diseases including diabetes (Larsen et al. 2010), obesity (Turnbaugh et al.”
BackgroundBriskey, D. R., Tucker, P. S., Johnson, D. W., & Coombes, J. S. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1255-y · Cited by 75
“Alterations in the balance of intestinal microbiota (dysbiosis) have been shown to contribute to the pathogenesis of a range of diseases including obesity [32], liver disease [33] and insulin resistance [34].”
Genomics and metagenomics in medical microbiology
Padmanabhan, R., Mishra, A. K., Raoult, D., & Fournier, P. (2013) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2013.10.006 · Cited by 72
“, 2008), type II diabetes (Larsen et al., 2010), obesity (Ley et al.”
BackgroundWoldeamlak, B., Yirdaw, K., & Biadgo, B. (2019) · The Korean Journal of Gastroenterology · doi:10.4166/kjg.2019.74.6.314 · Cited by 66
Isolation and hypoglycemic effects of water extracts from mulberry leaves in Northeast China
Han, X., Song, C., Feng, X., Wang, Y., Meng, T., Li, S., Bai, Y., Du, B., & Sun, Q. (2020) · Food & Function · doi:10.1039/d0fo00012d · Cited by 75
mbImpute: an accurate and robust imputation method for microbiome data
Jiang, R., Li, W. V., & Li, J. J. (2021) · Genome biology · doi:10.1186/s13059-021-02400-4 · Cited by 69
“[78] Nadja Larsen, Finn K Vogensen, Frans WJ Van Den Berg, Dennis Sandris Nielsen, 908 Anne Sofie Andreasen, Bente K Pedersen, Waleed Abu Al-Soud, Søren J Sørensen, Lars H 909 Hansen, and Mogens Jakobsen.”
BackgroundChen, L., Wang, Z., Wang, P., Yu, X., Ding, H., Wang, Z., & Feng, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00483-21 · Cited by 71
Su, L., Xin, C., Yang, J., Dong, L., Mei, H., Dai, X., & Wang, Q. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.06.071 · Cited by 69
New Aspects on the Metabolic role of Intestinal Microbiota in the Development of Atherosclerosis
Drosos, I., Tavridou, A., & Kolios, G. C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.007 · Cited by 70
“In this case, the ratio of Bacteroidetes to Firmicutes correlated with reduced glucose tolerance and, in contrast to the case of obesity, Bacteroidetes were higher in diabetic persons [27].”
BackgroundResultBugging inflammation: role of the gut microbiota
Shen, S., & Wong, C. H. Y. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.12 · Cited by 82
Reygner, J., Lichtenberger, L., Elmhiri, G., Dou, S., Bahi-Jaber, N., Rhazi, L., Dépeint, F., Bach, V., Khorsi‐Cauet, H., & Abdennebi‐Najar, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164614 · Cited by 72
The microbial reproductive ecology of white‐faced capuchins (Cebus capucinus)
Mallott, E. K., & Amato, K. R. (2018) · American Journal of Primatology · doi:10.1002/ajp.22896 · Cited by 72
Rude, K. M., Pusceddu, M. M., Keogh, C. E., Sladek, J. A., Rabasa, G., Miller, E. N., Sethi, S., Keil, K. P., Pessah, I. N., Lein, P. J., et al. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.07.066 · Cited by 73
Rettedal, E. A., Cree, J. M. E., Adams, S. E., MacRae, C. L., Skidmore, P. M. L., Cameron‐Smith, D., Gant, N., Blenkiron, C., & Merry, T. L. (2020) · Experimental Physiology · doi:10.1113/ep088744 · Cited by 72
“Diet-induced weight loss (Ley, Turnbaugh, Klein, & Gordon, 2006) and improvements in insulin sensitivity (Forslund et al., 2015; Larsen et al., 2010) have been associated with an increase in the Firmicutes-to-Bacteroides ratio.”
BackgroundVaresi, A., Deumer, U.-S., Ananth, S. V., & Ricevuti, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215077 · Cited by 73
Chen, Y., Ouyang, Y., Chen, X., Chen, R., Ruan, Q., Farag, M. A., Chen, X., & Zhao, C. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.05.109 · Cited by 68
Dietary Influences on Gut Microbiota with a Focus on Metabolic Syndrome
Thomas, M. S., Blesso, C. N., Calle, M. C., Chun, O. K., Puglisi, M. J., & Fernández, M. L. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0131 · Cited by 70
“32,33 Although some studies demonstrate that obese patients with MetS have a higher F/B ratio compared with ‘‘healthy obese’’ individuals, 34,35 it is not conclusive and needs to be investigated further.”
Fallucca, F., Porrata, C., Fallucca, S., & Pianesi, M. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2518 · Cited by 64
“Dysbiosis [23] is considered to be positively correlated with plasma glucose levels and the occurrence of T2DM, and Larsen et al. (2010) have characterized the composition of faecal bacteria from adults with T2DM, and observed a reduced proportion of Firmicutes and Clostridia species [22].”
BackgroundWang, Y., Ouyang, M., Gao, X., Wang, S., Fu, C., Zeng, J., & He, X. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s240728 · Cited by 68
Rosario, D., Boren, J., Uhlen, M., Proctor, G., Aarsland, D., Mardinoglu, A., & Shoaie, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00716 · Cited by 67
Gut microbiota and epilepsy: a systematic review on their relationship and possible therapeutics
Arulsamy, A., Tan, Q. Y., Balasubramaniam, V., O’Brien, T. J., & Shaikh, M. F. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00431 · Cited by 65
Diabetes and the Gut Microbiome
Lau, W. L., Tran, T., Rhee, C. M., Kalantar-Zadeh, K., & Vaziri, N. D. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.03.005 · Cited by 65
“It has been proposed that proliferation of gram-negative bacteria may explain the increase in serum endotoxin and low-grade systemic inflammation that is observed in both obesity and type 2 diabetes mellitus.(17,19,20) This pathologic pathway is amplified further when there is concurrent kidney disease.”
BackgroundImproving causality in microbiome research: can human genetic epidemiology help?
Wade, K. H., & Hall, L. J. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15628.3 · Cited by 48
“(A) MR relies on the following three core assumptions: (1) the genetic variant(s) being used as an instrument (Z) is associated with the exposure (X); (2) the genetic variant(s) are independent of measured and unmeasured confounders (U) of the association between the exposure (X) and outcome (Y); and (3) there is no i…”
Huang, H.-J., Chen, J.-L., Liao, J.-F., Chen, Y., Chieu, M.-W., Ke, Y.-Y., Hsu, C.-C., Tsai, Y.-C., & Hsieh‐Li, H. M. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03426-8 · Cited by 68
Bastos, R. M. C., Simplício-Filho, A., Sávio-Silva, C., de Oliveira, L. F. V., Cruz, G. N. F., Sousa, E. H., Noronha, I. L., Mangueira, C. L. P., Quaglierini-Ribeiro, H., Josefi-Rocha, G. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073842 · Cited by 70
“In treated BTBRob/ob mice, body weight correlated positively to the Betaproteobacteria class, Gram-negative bacteria belonging to the Proteobacteria phylum, which are highly enriched in diabetic individuals and positively correlated to plasma glucose [11].”
BackgroundResultInfluentialFarag, M. A., Rezk, M. M., Elashal, M. H., El‐Araby, M. E., Khalifa, S. A. M., & El-Seedi, H. R. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111853 · Cited by 73
Humpback whales harbour a combination of specific and variable skin bacteria
Apprill, A. M., Mooney, T. A., Lyman, E., Stimpert, A. K., & Rappé, M. S. (2010) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2010.00213.x · Cited by 74
“Microorganisms are abundantly associated with mammals, and recent studies have demonstrated that the composition of these communities can be related to the health and ecology of the host (Ley et al., 2008; Costello et al., 2009; Grice et al., 2009; Hartman et al., 2009; Larsen et al., 2010).”
BackgroundHang, J., Desai, V., Zavaljevski, N., Yang, Y., Lin, X., Satya, R. V., Martinez, L. J., Blaylock, J. M., Jarman, R. G., Thomas, S. J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-31 · Cited by 65
“[11-13], obesity [14,15], and type II diabetes [16,17].”
BackgroundRomero, R., & Korzeniewski, S. J. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.12.026 · Cited by 66
How poverty affects diet to shape the microbiota and chronic disease
Harrison, C. A., & TAREN, D. L. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.121 · Cited by 71
Jergens, A. E., Guard, B. C., Redfern, A., Rossi, G., Mochel, J. P., Pilla, R., Chandra, L. C., Seo, Y., Steiner, J. M., Lidbury, J. A., et al. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00199 · Cited by 73
“Alterations in gut microbiota composition have been linked to the development of human metabolic diseases, including both T1DM and T2DM (2, 3, 24, 25).”
BackgroundZhao, Z., Shi, A., Wang, Q., & Zhou, J. (2019) · Nutrients · doi:10.3390/nu11123005 · Cited by 70
Vetrani, C., Maukonen, J., Bozzetto, L., Della Pepa, G., Vitale, M., Costabile, G., Riccardi, G., Rivellese, A. A., Saarela, M., & Annuzzi, G. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01494-9 · Cited by 64
Ma, W., Chen, J., Meng, Y., Yang, J., Cui, Q., & Zhou, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01336 · Cited by 64
“Moreover, in the gut of human subjects with type 2 diabetes, Firmicutes is significantly decreased (Larsen et al., 2010).”
BackgroundEjtahed, H., Tavassol, Z. H., Khatami, S., Zangeneh, M., Behrouzi, A., Badi, S. A., Moshiri, A., Hasani‐Ranjbar, S., Soroush, A., Vaziri, F., et al. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00502-7 · Cited by 70
Impact of Phlorotannin Extracts from Fucus vesiculosus on Human Gut Microbiota
Catarino, M. D., Marçal, C., Bonifácio-Lopes, T., Campos, D. A., Mateus, N. F. D. C. B., Silva, A. M. S., Pintado, M. M., & Cardoso, S. M. (2021) · Marine Drugs · doi:10.3390/md19070375 · Cited by 65
“For instance, increased F:B ratios have been linked to the pathophysiology of obesity [40], while patients of type II diabetes mellitus were found to have their levels of Firmicutes significantly reduced compared to their non-diabetic counterparts and consequently had decreased F:B ratios [41].”
BackgroundLiu, J., Wu, S., Yang, C., Liu, Q., Su, L., Yang, Y., Zhang, X., Wu, M., Choi, J., & Tong, H. (2021) · Nutrients · doi:10.3390/nu13082887 · Cited by 68
“Lipopolysaccharide (LPS) was determined by a ELISA kit (Jianchen Bioengineering Institute, Nanjing, China).”
BackgroundInfluentialGut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus
Duan, L., An, X., Zhang, Y., Jin, D., Zhao, S., Zhou, R., Duan, Y., Zhang, Y., Liu, X., & Lian, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112094 · Cited by 70
Two Blautia Species Associated with Visceral Fat Accumulation: A One-Year Longitudinal Study
Ozato, N., Yamaguchi, T. F., Mori, K., Katashima, M., Kumagai, M., Murashita, K., Katsuragi, Y., Tamada, Y., Kakuta, M., Imoto, S., et al. (2022) · Biology · doi:10.3390/biology11020318 · Cited by 77
“However, Blautia is reportedly less prominent in obese children [54], diabetic adults, and pediatric patients [55,56], as well as subjects with other diseases, such as rectal cancer and rheumatoid arthritis [57,58], than in healthy subjects.”
BackgroundUpdates on the Role of Probiotics against Different Health Issues: Focus on Lactobacillus
Un-Nisa, A., Khan, A., Zakria, M., Siraj, S., Ullah, S., Tipu, M. K., Ikram, M. A., & Kim, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010142 · Cited by 69
“It was also suggested that by regulating the gut flora there is reduced insulin resistance and overall reduced symptoms associated with diabetes mellitus type-2 [73].”
BackgroundNistal, E., de Miera, L. E. S., Ballesteros-Pomar, M. D., Sánchez‐Campos, S., García‐Mediavilla, M. V., Álvarez-Cuenllas, B., Linares, P., Olcoz, J. L., Arias, M., Lobo, J. M. G., et al. (2019) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2019.6068/2018 · Cited by 72
“The pathophysiology of NAFLD remains unclear but the intestinal microbiome has recently gained great attention in metabolic diseases, as gut dysbiosis has been recognized in obesity (3,4), the metabolic syndrome (5), diabetes (6-8) and cardiovascular diseases (9).”
BackgroundZhao, L., Wang, Y., Zhang, G., Zhang, T., Lou, J., & Liu, J. (2019) · Nutrients · doi:10.3390/nu11123054 · Cited by 65
“CGCGTCYGGTGTGAAAG CCCCACATCCAGCATCCA [38] Lactobacillus group AGCAGTAGGGAATCTTCCA CACCGCTACACATGGAG [39] Domain bacteria universal TCCTACGGGAGGCAGCAGT GGACTACCAGGGTATCTAATCCTGTT [40]”
BackgroundTakahashi, S., Luo, Y., Ranjit, S., Xie, C., Libby, A. E., Orlicky, D. J., Dvornikov, A. S., Wang, X. X., Myakala, K., Jones, B. A., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011913 · Cited by 67
Urbaniak, C., Lorenzi, H., Thissen, J. B., Jaing, C. J., Crucian, B. E., Sams, C. F., Pierson, D. L., Venkateswaran, K. J., & Mehta, S. K. (2020) · Microbiome · doi:10.1186/s40168-020-00830-z · Cited by 72
“Changes in the composition of one’s microbiome may promote the development of the aforementioned NIDs, as individuals with inflammatory bowel disease [3, 4], asthma [5], diabetes [6], cardiovascular disease [7], colorectal cancer [8], and breast cancer [9] have different bacterial communities than healthy individuals.”
From obesity through gut microbiota to cardiovascular diseases: a dangerous journey
Marzullo, P., Renzo, L. D., Pugliese, G., Siena, M. D., Barrea, L., Muscogiuri, G., Colao, A., & Savastano, S. (2020) · International Journal of Obesity Supplements · doi:10.1038/s41367-020-0017-1 · Cited by 71
Sanduzzi Zamparelli, M., Compare, D., Coccoli, P., Rocco, A., Nardone, O., Marrone, G., Gasbarrini, A., Grieco, A., Nardone, G., & Miele, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081225 · Cited by 59
Zhu, G., Ma, F., Wang, G., Wang, Y., Zhao, J., Zhang, H., & Chen, W. (2018) · Food & Function · doi:10.1039/c8fo00100f · Cited by 67
Circadian Rhythms, the Gut Microbiome, and Metabolic Disorders
Zhao, E. H., Tait, C., Minacapelli, C. D., Catalano, C., & Rustgi, V. K. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2021.10.008 · Cited by 68
“65 Variations in the gut microbiota have also been associated with metabolic disorders of the liver and the development of NAFLD and NASH as well as hepatocellular carcinoma.”
BackgroundNeuro-consequences of the spaceflight environment
Mhatre, S. D., Iyer, J. S., Puukila, S., Paul, A. M., Tahimic, C. G. T., Rubinstein, L., Lowe, M. G., Alwood, J. S., Sowa, M. B., Bhattacharya, S., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.055 · Cited by 69
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 72
Bai, Z., Huang, X., Wu, G., Ye, H., Huang, W., Nie, Q., Chen, H., Yin, J., Chen, Y., & Nie, S. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134598 · Cited by 69
Du, L., Lv, H., Chen, Y., Yu, X., Jian, T., Zhao, H., Wu, W., Ding, X., Chen, J., & Li, W. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c04606 · Cited by 64
Bias in bacterial diversity as a result of Nycodenz extraction from bulk soil
Holmsgaard, P. N., Norman, A., Hede, S. C., Poulsen, P. H. B., Al‐Soud, W. A., Hansen, L. H., & Sørensen, S. J. (2011) · Soil Biology and Biochemistry · doi:10.1016/j.soilbio.2011.06.019 · Cited by 70
Self-citationAraújo, J. R., Martel, F., & Keating, E. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.09.007 · Cited by 73
The Role of the gut Microbiome in the Pathogenesis and Treatment of Obesity
Okeke, F., Roland, B. C., & Mullin, G. E. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2014.018 · Cited by 62
Hidalgo, M., Prieto, I., Abriouel, H., Villarejo, A. B., Ramírez‐Sánchez, M., Cobo, A., Benomar, N., Gálvez, A., & Martínez‐Cañamero, M. (2017) · Plant Foods for Human Nutrition · doi:10.1007/s11130-017-0650-1 · Cited by 63
“All bacteria univF TCCTACGGGAGGCAGCAGT 466 [9] univR GACTACCAGGGTATCTAATCCTGTT”
BackgroundTorres, P. J., Skarra, D. V., Ho, B., Sau, L., Anvar, A. R., Kelley, S. T., & Thackray, V. G. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1425-7 · Cited by 70
Zheng, Y., Yu, J., Liang, C., Li, S., Wen, X., & Li, Y. (2020) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-020-02320-w · Cited by 64
Luo, Y., Zhang, L., Li, H., Smidt, H., Wright, A. G., Zhang, K., Ding, X., Zeng, Q., Bai, S., Wang, J., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00966 · Cited by 69
“, 2012), Prevotella (Larsen et al., 2010), Methanogens (Denman et al.”
BackgroundThe gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
Segal, J. P., Mak, J. W. Y., Mullish, B. H., Alexander, J. L., Ng, S. C., & Marchesi, J. R. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820974914 · Cited by 64
“29 The presence of Bifido-bacterium, Bacteroides, Faecalibactrium, Akkermansia and Roseburia was suggested to be protective against type 2 DM, while Ruminococcus, Fusobacterium and Blautia were found to be positively associated with type 2 DM. 30 There have also been studies showing that the use of…”
BackgroundComparison of Blood Bacterial Communities in Periodontal Health and Periodontal Disease
Emery, D. C., Cerajewska, T. L., Seong, J., Davies, M., Paterson, A. R., Allen, S. J., & West, N. X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.577485 · Cited by 69
Management of chronic constipation in patients with diabetes mellitus
Prasad, V. G. M., & Abraham, P. (2016) · Indian Journal of Gastroenterology · doi:10.1007/s12664-016-0724-2 · Cited by 69
Chen, Y., Li, Z., Hu, S., Zhang, J., Wu, J., Shao, N., Bo, X., Ni, M., & Ying, X. (2017) · Microbiome · doi:10.1186/s40168-017-0232-3 · Cited by 65
“Consistent with previous reports, we found that, relative to the HC group, the T2D group had lower proportions of phylum Firmicutes, class Clostridia, and butyrateproducing bacteria (Additional file 2: Figure S1) [2, 3].”
BackgroundResultGut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus
Zhang, B., Yue, R., Chen, Y., Yang, M., Huang, X., Shui, J., Peng, Y., & Chin, J. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2634898 · Cited by 66
Wu, R., Zhao, D., An, R., Wang, Z., Li, Y., Shi, B., & Ni, Q. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00918 · Cited by 64
Acosta-Montaño, P., Rodríguez‐Velázquez, E., Ibarra-López, E., Frayde-Gómez, H., Mas‐Oliva, J., Delgado‐Coello, B., Rivero, I. A., Alatorre‐Meda, M., Aguilera, J., Guevara-Olaya, L., et al. (2019) · Cells · doi:10.3390/cells8080884 · Cited by 63
Metadata
- Authors
- Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Larsen, Nadja
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9085
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2816710
- OpenAlex
- W2135989088
- Cited by
- 2,952
- References
- 38
- Citations by year
- 2026: 90 · 2025: 168 · 2024: 217 · 2023: 199 · 2022: 296 · 2021: 331 · 2020: 294 · 2019: 264 · 2018: 191 · 2017: 158 · 2016: 174 · 2015: 150 · 2014: 134 · 2013: 115 · 2012: 83
- FWCI
- 36.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, Firmicutes, Bacteroidetes, Betaproteobacteria, plasma glucose, glucose tolerance, obesity, metabolic disorders, 16S rRNA gene
- MeSH terms
- Adult, Aged, Bacteria, Diabetes Mellitus, Type 2, DNA, Bacterial, Feces, Humans, Intestines, Male, Middle Aged, RNA, Ribosomal, 16S, Colony Count, Microbial, Body Mass Index, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.